Chemical Biology and Medicinal Chemistry

Chemical biology and medicinal chemistry

We focus on the application of chemical approaches to problems in biology and medicine. By advancing our understanding of the molecular basis of life, we open new opportunities for treating diseases as diverse as cancer, bacterial and viral infections, and neurodegenerative diseases.

Our research is underpinned by expertise in chemical synthesis, medicinal chemistry, molecular recognition, enzymology, biophysical and analytical methods, and nanoscience. Our work is inherently interdisciplinary and we work closely in collaboration with biologists, medics and industrial partners.

Chemical biology

Applying chemical methods to the study of biological problems is a key interest in the group. Research in this area focuses on:

  • Developing chemical tools and approaches for interrogating complex biological systems
  • Elucidation of fundamental biological mechanisms
  • Engineered and modified proteins: methods and applications in industrial biotechnology

These research interests are largely coordinated through the Astbury Centre for Structural Molecular Biology.

Medicinal chemistry

We focus on the discovery and optimisation of bioactive molecules for a wide range of potential therapeutic targets. Research in this area focuses on:

  • Early-stage drug discovery
  • Targeted delivery systems for imaging and/or therapeutics
  • Technologies for disease diagnosis

Many of these activities are undertaken in collaboration with the University's biomedical research groups.

PhD projects

We have opportunities for prospective postgraduate researchers. Find out more.

We also supervise students on the following doctoral training programmes which typically have application deadlines in January each year:

Major research projects and links with industry

Members of the chemical biology and medicinal chemistry group lead or participate in a number of large multi-centre and multinational projects funded by UKRI and the European Union:

  • PoPPI -  Perturbation of Protein-Protein Interactions
  • synBIOcarb - Synthetic Glycobiology for cancer diagnostics and drug targeting
  • TASPPI - Targeted small-molecule Stabilisation of Protein-Protein Interactions

We have strong links to the pharmaceutical and biotechnology sectors, and many projects are undertaken in collaboration with industry.

Facilities

  • A facility for screening small molecule libraries
  • A suite dedicated to the high-throughput synthesis of small molecules
  • Computer cluster dedicated to ligand design
  • Integrated laboratories for protein engineering and chemical biology research

Access to all major structural biology and biophysical techniques is available through the Astbury Centre for Structural Molecular Biology. The £17million Astbury BioStructure laboratory has internationally-leading facilities for cryo-electron microscopy and biological NMR spectrometry.

Research team

Further information

View all members of our research group and publications.

Contact us

If you are interested in collaborating with us or joining our research team, please get in touch with a relevant member.